380 related articles for article (PubMed ID: 28669615)
1. Long-term protection after hepatitis B vaccination in people living with HIV.
Lara AN; Sartori AM; Fonseca MO; Lopes MH
Vaccine; 2017 Jul; 35(33):4155-4161. PubMed ID: 28669615
[TBL] [Abstract][Full Text] [Related]
2. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Avdicova M; Crasta PD; Hardt K; Kovac M
Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
[TBL] [Abstract][Full Text] [Related]
3. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
[TBL] [Abstract][Full Text] [Related]
4. Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah.
Mahallawi W
Ann Saudi Med; 2018; 38(6):413-419. PubMed ID: 30531175
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
[TBL] [Abstract][Full Text] [Related]
6. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
[TBL] [Abstract][Full Text] [Related]
7. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
McMahon BJ; Bruden DL; Petersen KM; Bulkow LR; Parkinson AJ; Nainan O; Khristova M; Zanis C; Peters H; Margolis HS
Ann Intern Med; 2005 Mar; 142(5):333-41. PubMed ID: 15738452
[TBL] [Abstract][Full Text] [Related]
8. Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations.
Yoshioka N; Deguchi M; Hagiya H; Kagita M; Tsukamoto H; Takao M; Yoshida H; Yamamoto N; Akeda Y; Nabetani Y; Maeda I; Hidaka Y; Tomono K
PLoS One; 2017; 12(11):e0187661. PubMed ID: 29121107
[TBL] [Abstract][Full Text] [Related]
9. [Influence of three booster doses hepatitis B vaccine on the persistence of immune-protection among infants with normal and high antibody response to primary vaccination: a matched case-control study].
Feng Y; Lyu J; Liu J; Yan B; Song L; Liang X; Li L; Zhang G; Wang F; Zhang L; Xu A
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Apr; 37(4):460-3. PubMed ID: 27087206
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
11. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
Alanko Blomé M; Björkman P; Flamholc L; Jacobsson H; Widell A
Vaccine; 2017 Jan; 35(1):84-90. PubMed ID: 27894721
[TBL] [Abstract][Full Text] [Related]
13. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
[TBL] [Abstract][Full Text] [Related]
14. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
[TBL] [Abstract][Full Text] [Related]
15. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
16. Suitable hepatitis B vaccine for adult immunization in China.
Yang L; Yao J; Li J; Chen Y; Jiang ZG; Ren JJ; Xu KJ; Ruan B; Yang SG; Wang B; Xie TS; Li Q
Immunol Res; 2016 Feb; 64(1):242-50. PubMed ID: 26645972
[TBL] [Abstract][Full Text] [Related]
17. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
[TBL] [Abstract][Full Text] [Related]
18. Anti-HBs levels among children and adolescents with complete immunization schedule against hepatitis B virus. A cross-sectional study in Blumenau, State of Santa Catarina, Brazil, 2007-2008.
Livramento Ad; Cordova CM; Scaraveli NG; Tonial GC; Spada C; Treitinger A
Rev Soc Bras Med Trop; 2011; 44(4):412-5. PubMed ID: 21789351
[TBL] [Abstract][Full Text] [Related]
19. Persistence of Hepatitis B Immunity Following 3-dose Infant Primary Series in HIV-infected Thai Adolescents and Immunologic Response to Revaccination.
Lapphra K; Angkhananukit P; Saihongthong S; Phongsamart W; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
Pediatr Infect Dis J; 2017 Sep; 36(9):863-868. PubMed ID: 28419007
[TBL] [Abstract][Full Text] [Related]
20. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]